Biotech · Private company
Purdue Pharma LP
Track this companyFree. Adds Purdue Pharma LP to your Dealase workspace and tells you when its record changes.
Clinical trials170 recruiting or active
Pipeline programs10From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline10
- Hydrocodone bitartrate q24h film-coated tabletsPhase 3 · Chronic Nonmalignant and Nonneuropathic PainClinicalTrials.gov · fetched Nov 12, 2026
- Hydrocodone bitartrate q24h film-coated tabletsPhase 3 · Chronic Low Back PainClinicalTrials.gov · fetched Nov 12, 2026
- Oxycodone HCl controlled-release tabletsPhase 3 · PainClinicalTrials.gov · fetched Nov 12, 2026
- NaproxenPhase 2 · Osteo Arthritis KneeClinicalTrials.gov · fetched Nov 12, 2026
- V120083Phase 2 · Osteo Arthritis KneeClinicalTrials.gov · fetched Nov 12, 2026
- Nalmefene HCl injectionPhase 1 · Opioid OverdoseClinicalTrials.gov · fetched Nov 12, 2026
- Naloxone HCl intranasalPhase 1 · Opioid OverdoseClinicalTrials.gov · fetched Nov 12, 2026
- Adhansia XRAttention Deficit/Hyperactivity DisorderClinicalTrials.gov · fetched Nov 12, 2026
- ConcertaAttention-Deficit/Hyperactivity DisorderClinicalTrials.gov · fetched Nov 12, 2026
- WHTChronic PainClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials17
- Pharmacokinetic (PK) Evaluation of Nalmefene FormulationsPHASE1 · COMPLETED · started Feb 6, 2026ClinicalTrials.gov NCT07543276 · fetched Nov 12, 2026
- Pharmacodynamic Evaluation of Intramuscular Nalmefene Autoinjector 1.5 mg Compared to Intranasal Narcan 4 mgPHASE1 · COMPLETED · started Oct 3, 2022ClinicalTrials.gov NCT06719986 · fetched Nov 12, 2026
- Study of V117957 in Overactive Bladder SyndromePHASE1 · COMPLETED · started Jun 30, 2022ClinicalTrials.gov NCT06024642 · fetched Nov 12, 2026
- Study of V117957 in Interstitial Cystitis/Bladder Pain SyndromePHASE1 · COMPLETED · started May 26, 2022ClinicalTrials.gov NCT06285214 · fetched Nov 12, 2026
- Safety and Tolerability Study of Adhansia XR® Extended-Release Capsules in ChildrenPHASE4 · TERMINATED · started Aug 3, 2021ClinicalTrials.gov NCT04987762 · fetched Nov 12, 2026
- Real-World Evidence of Duration of Effect of Adhansia XR (Extended-Release) for Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD)PHASE4 · TERMINATED · started Jul 30, 2020ClinicalTrials.gov NCT04507204 · fetched Nov 12, 2026
- Safety, Tolerability and Efficacy Study of V117957 in Subjects With Insomnia Associated With Alcohol CessationPHASE2 · COMPLETED · started Sep 23, 2019ClinicalTrials.gov NCT04035200 · fetched Nov 12, 2026
- Study to Evaluate the Respiratory Safety of Lemborexant in Adult and Elderly Healthy Subjects and Adult and Elderly Subjects With Mild Obstructive Sleep ApneaPHASE1 · COMPLETED · started Feb 21, 2018ClinicalTrials.gov NCT03471871 · fetched Nov 12, 2026
- Study to Evaluate the Pharmacokinetics of Lemborexant (E2006) and Its Metabolites in Subjects With Normal Renal Function or With Severe Renal ImpairmentPHASE1 · COMPLETED · started Feb 7, 2018ClinicalTrials.gov NCT03443063 · fetched Nov 12, 2026
- Study to Evaluate the Pharmacokinetics of Lemborexant (E2006) and Its Metabolites in Subjects With Mild and Moderate Hepatic Impairment Compared to Healthy SubjectsPHASE1 · COMPLETED · started Jan 26, 2018ClinicalTrials.gov NCT03440424 · fetched Nov 12, 2026
- Effect of Wearable Health Technology on Patients Treated for Chronic Pain at Geisinger Health SystemCOMPLETED · started Oct 5, 2017ClinicalTrials.gov NCT03299556 · fetched Nov 12, 2026
- A Study to Evaluate the Analgesic Efficacy and Safety of V120083 in Subjects With Osteoarthritis (OA) of the KneePHASE2 · COMPLETED · started Mar 14, 2017ClinicalTrials.gov NCT03028870 · fetched Nov 12, 2026
- Study of Lemborexant for Irregular Sleep-Wake Rhythm Disorder and Mild to Moderate Alzheimer's Disease DementiaPHASE2 · COMPLETED · started Dec 20, 2016ClinicalTrials.gov NCT03001557 · fetched Nov 12, 2026
- Crossover Study to Evaluate the Effect of Lemborexant Versus Placebo and Zolpidem on Postural Stability, Auditory Awakening Threshold, and Cognitive Performance in Healthy Subjects 55 Years and OlderPHASE1 · COMPLETED · started Nov 21, 2016ClinicalTrials.gov NCT03008447 · fetched Nov 12, 2026
- Efficacy and Safety of Hydrocodone Bitartrate (HYD) in Subjects With Moderate to Severe Chronic Low Back PainPHASE3 · COMPLETED · started Oct 1, 2011ClinicalTrials.gov NCT01452529 · fetched Nov 12, 2026
- Long-term Safety of Once-daily Hydrocodone Bitartrate (HYD) Tablets For Moderate to Severe Chronic Nonmalignant and Nonneuropathic Pain. Includes a 24-week Extension Period.PHASE3 · COMPLETED · started Jul 1, 2011ClinicalTrials.gov NCT01400139 · fetched Nov 12, 2026
- Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring OpioidsPHASE3 · COMPLETED · started Nov 1, 2010ClinicalTrials.gov NCT01192295 · fetched Nov 12, 2026